NL192205C - Process for preparing 7-amino-3- (Z-1-propenyl) -3-cephem-4-carboxylic acid and esters thereof. - Google Patents
Process for preparing 7-amino-3- (Z-1-propenyl) -3-cephem-4-carboxylic acid and esters thereof. Download PDFInfo
- Publication number
- NL192205C NL192205C NL8601011A NL8601011A NL192205C NL 192205 C NL192205 C NL 192205C NL 8601011 A NL8601011 A NL 8601011A NL 8601011 A NL8601011 A NL 8601011A NL 192205 C NL192205 C NL 192205C
- Authority
- NL
- Netherlands
- Prior art keywords
- formula
- liters
- solution
- stirred
- mixture
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- ZYLDQHILNOZKIF-AATZEOSQSA-N (6r)-7-amino-8-oxo-3-[(z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(\C=C/C)=C(C(O)=O)N2C(=O)C(N)[C@@H]12 ZYLDQHILNOZKIF-AATZEOSQSA-N 0.000 title description 3
- 150000002148 esters Chemical class 0.000 title description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 14
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims description 12
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 125000006239 protecting group Chemical group 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 239000013078 crystal Substances 0.000 claims description 5
- 229910052751 metal Chemical class 0.000 claims description 5
- 239000002184 metal Chemical class 0.000 claims description 5
- 239000012044 organic layer Substances 0.000 claims description 5
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 3
- 239000010410 layer Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000012430 organic reaction media Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims 2
- IFQUPKAISSPFTE-UHFFFAOYSA-N 4-benzoylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(=O)C1=CC=CC=C1 IFQUPKAISSPFTE-UHFFFAOYSA-N 0.000 claims 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 claims 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 1
- 238000007605 air drying Methods 0.000 claims 1
- 239000006286 aqueous extract Substances 0.000 claims 1
- -1 vinyl cephalosporins Chemical class 0.000 description 8
- 235000019439 ethyl acetate Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000007239 Wittig reaction Methods 0.000 description 6
- 229940124587 cephalosporin Drugs 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- 229930186147 Cephalosporin Natural products 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 101100167062 Caenorhabditis elegans chch-3 gene Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- YSULOORXQBDPCU-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethanehydrazonate;hydrochloride Chemical compound [Cl-].C[N+](C)(C)CC(=O)NN YSULOORXQBDPCU-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- GRMFXNQIRFLDLC-RQRXLDSQSA-M [(6R)-2-benzhydryloxycarbonyl-7-(benzylideneamino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl-triphenylphosphanium chloride Chemical compound [Cl-].C(C1=CC=CC=C1)=NC1[C@@H]2N(C(=C(CS2)C[P+](C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C(=O)OC(C2=CC=CC=C2)C2=CC=CC=C2)C1=O GRMFXNQIRFLDLC-RQRXLDSQSA-M 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004849 alkoxymethyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- AEECHDKJQFHHEH-YFVGKJKASA-N benzhydryl (6R)-7-(benzylideneamino)-8-oxo-3-[(triphenyl-lambda5-phosphanylidene)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C(C1=CC=CC=C1)=NC1[C@@H]2N(C(=C(CS2)C=P(C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C(=O)OC(C2=CC=CC=C2)C2=CC=CC=C2)C1=O AEECHDKJQFHHEH-YFVGKJKASA-N 0.000 description 1
- HDYOATPRFNMLSX-ALAWQYECSA-N benzhydryl (6r)-7-amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrochloride Chemical compound Cl.S([C@@H]1C(C(N11)=O)N)CC(CCl)=C1C(=O)OC(C=1C=CC=CC=1)C1=CC=CC=C1 HDYOATPRFNMLSX-ALAWQYECSA-N 0.000 description 1
- KGHADALWBFAJHM-SOSCOHMFSA-N benzhydryl (6r)-7-amino-8-oxo-3-[(z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound S([C@H]1N2C(C1N)=O)CC(\C=C/C)=C2C(=O)OC(C=1C=CC=CC=1)C1=CC=CC=C1 KGHADALWBFAJHM-SOSCOHMFSA-N 0.000 description 1
- BZFZFEUVSJDIEZ-ICSMSXPMSA-N benzhydryl (6r)-7-amino-8-oxo-3-[(z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrochloride Chemical compound Cl.S([C@H]1N2C(C1N)=O)CC(\C=C/C)=C2C(=O)OC(C=1C=CC=CC=1)C1=CC=CC=C1 BZFZFEUVSJDIEZ-ICSMSXPMSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- WDCDAAMJNUHOIY-UHFFFAOYSA-N ethyl acetate;2-propan-2-yloxypropane Chemical compound CCOC(C)=O.CC(C)OC(C)C WDCDAAMJNUHOIY-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- VBQCHPIMZGQLAZ-UHFFFAOYSA-N phosphorane Chemical class [PH5] VBQCHPIMZGQLAZ-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- OODSAKPEXJRFOF-FQSXHJSUSA-M potassium;(6r,7r)-7-amino-8-oxo-3-[(z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [K+].S1CC(\C=C/C)=C(C([O-])=O)N2C(=O)[C@@H](N)[C@@H]12 OODSAKPEXJRFOF-FQSXHJSUSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Description
1 1922051 192205
Werkwijze voor het bereiden van 7-amino-3-(Z-1-propenyl)-3-cefem-4-carbonzuur en esters daarvanProcess for the preparation of 7-amino-3- (Z-1-propenyl) -3-cephem-4-carboxylic acid and esters thereof
De uitvinding heeft betrekking op een werkwijze voor het bereiden van een verbinding met formule 1, waarin de 3-propenylgroep de Z-configuratie heeft en R waterstof of een conventionele carboxyl-beschermende 5 groep voorstelt, alsmede zuuradditiezouten daarvan en metaalzouten van de stof waarin R waterstof voorstelt, waarbij men een tussenproduct met formule 10, waarin R de voomoemde betekenis heeft en Ph een fenylgroep voorstelt, laat reageren met aceetaldehyde in een inert organisch reactiemedium omvattende dichloormethaan, Ν,Ν-dimethyKoimamide, isopropylalcohol of een mengsel daarvan, bij een reactie-temperatuur tussen 0 en 25°C, waarbij een verbinding met formule 11 wordt verkregen, en daarna de 10 benzylideengroep of zowel de benzylideengroep als de carboxylbeschermende groep worden verwijderd.The invention relates to a process for preparing a compound of formula 1, wherein the 3-propenyl group has the Z-configuration and R represents hydrogen or a conventional carboxyl-protecting group, as well as acid addition salts thereof and metal salts of the substance in which R hydrogen, whereby an intermediate of formula 10, in which R has the above meaning and Ph represents a phenyl group, is reacted with acetaldehyde in an inert organic reaction medium comprising dichloromethane, Ν, Ν-dimethykimamide, isopropyl alcohol or a mixture thereof, in a reaction temperature between 0 and 25 ° C, whereby a compound of formula 11 is obtained, and then the benzylidene group or both the benzylidene group and the carboxyl protecting group are removed.
Uit het Amerikaanse octrooischrift 4.110.534 is een grote klasse 3-vinyl· en gesubstitueerd-vinylcefalosporinen en hun bereiding bekend. Tot deze klasse behoren 7-amino-3-(Z-1-propenyl)-3-cefem-4-carbonzuur en esters daarvan. Deze veibindingen kunnen worden bereid door een 3-(trifenylfosforanylideen-methyl)-cefalosporine te onderwerpen aan een Wittig-reactie. In deze publicatie wordt een aantal 15 verhoudingen genoemd van Z- en E-isomeren in het eindproduct. In voorbeeld 21 van dit octrooischrift wordt een opbrengst van 17% vermeld, die grotendeels uit het cis-isomeer en voor slechts 5-10% uit het trans-isomeer bestaat. Er wordt echter niet vermeld hoe die verhoudingen beïnvloed kunnen worden.U.S. Pat. No. 4,110,534 discloses a high class 3 vinyl and substituted vinyl cephalosporins and their preparation. This class includes 7-amino-3- (Z-1-propenyl) -3-cephem-4-carboxylic acid and its esters. These fibers can be prepared by subjecting a 3- (triphenylphosphoranylidenemethyl) -cephalosporin to a Wittig reaction. In this publication, a number of ratios of Z and E isomers in the final product are mentioned. Example 21 of this patent discloses a yield of 17% consisting largely of the cis isomer and only 5-10% of the trans isomer. However, it is not stated how these relationships can be influenced.
Van de verbindingen die volgens de onderhavige werkwijze worden bereid, is de Z- of cis-configuratie van de 3-propenylgroep een kritische eigenschap. Deze configuratie bepaalt de voordelige eigenschappen 20 tegen Gram-negatieve bacteriën van de cefalosporine-eindproducten die het onderwerp vormen van het Amerikaanse octrooischrift 4.520.022.Of the compounds prepared by the present method, the Z or cis configuration of the 3-propenyl group is a critical property. This configuration determines the beneficial properties against Gram negative bacteria of the cephalosporin end products that are the subject of U.S. Patent 4,520,022.
Doel van de onderhavige uitvinding is een gunstige Z-/E-isomere verhouding te realiseren in combinatie met een hoge chemische opbrengst.The object of the present invention is to realize a favorable Z- / E-isomeric ratio in combination with a high chemical yield.
Dit doel wordt bereikt door een Wittig-reactie met geschikte uitgangsproducten uit te voeren in aanwezig-25 heid van lithiumbromide.This object is achieved by carrying out a Wittig reaction with suitable starting products in the presence of lithium bromide.
De werkwijze volgens de uitvinding wordt daardoor gekenmerkt, dat de reactie met aceetaldehyde wordt uitgevoerd in aanwezigheid van lithiumbromide en desgewenst de 3-(Z)- en 3-(E)-isomeren worden gescheiden om een verbinding te krijgen met formule 1 waarin R dezelfde betekenissen heeft als hiervoor.The process of the invention is characterized in that the reaction with acetaldehyde is carried out in the presence of lithium bromide and, optionally, the 3- (Z) and 3- (E) isomers are separated to obtain a compound of formula 1 wherein R is the same has meanings as before.
Overigens is uit het Amerikaanse octrooischrift 4.065.620 bekend, dat 3-(gesubstitueerd)-vinylcefalo-30 sponnen ook bereid kunnen worden door de Wittig-reactie uit te voeren met een 3-(gesubstitueerd)-formyl-cefalosporinesulfide of -sulfoxide en een fosforaanderivaat.Incidentally, it is known from U.S. Pat. No. 4,065,620 that 3- (substituted) -vinylcephalo-30 spuns can also be prepared by carrying out the Wittig reaction with a 3- (substituted) -formyl-cephalosporin sulfide or sulfoxide and a phosphorane derivative.
In het Britse octrooischrift 1.342.241 wordt de verbinding met formule 2 beschreven, maar er is geen sprake van een beschrijving van 7p-animo-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carbonzuur als tussenproduct in de bereiding daarvan.British Patent 1,342,241 describes the compound of formula II, but there is no description of 7p-animo-3 - [(Z) -1-propen-1-yl] -3-cefem-4- carboxylic acid as an intermediate in its preparation.
35 In het Amerikaanse octrooischrift 4.409.214 wordt de bereiding beschreven van de verbinding met formule 3 via een Wittig-reactie aan drfenylmethyl-7-benzylideenamino-3-trifenyl-fosfoniomethylcef-3-em-4-carboxyplaat in de bereidingsvoorbeelden 38 en 39, maar er is geen sprake van een beschrijving van 7p-amino-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carbonzuur, noch van een andere 3-(1 -propen-1 -yl)-cefaiosporineverbinding.U.S. Patent No. 4,409,214 describes the preparation of the compound of formula 3 via a Wittig reaction on drphenylmethyl-7-benzylideneamino-3-triphenylphosphoniomethylceph-3-em-4-carboxy plate in Preparation Examples 38 and 39, but there is no description of 7p-amino-3 - [(Z) -1-propen-1-yl] -3-cefem-4-carboxylic acid, nor of any other 3- (1-propen-1 - yl) -cephaiosporin compound.
40 Door H. O. House et al. Jour. Oig. Chem. 29, 3327-3 333 (1964) is het effect bestudeerd van oplosmiddelen en additieven met inbegrip van lithiumzouten op de hoeveelheden cis- en trans-alkenen die in de Wittig-reactie met aldehyden worden geproduceerd. In deze publicatie wordt echter nergens een combinatie van een hoge chemische opbrengst met een gunstige Z-/E-isomere verhouding vermeld.40 By H.O. House et al. Jour. Oig. Chem. 29, 3327-3 333 (1964) has studied the effect of solvents and additives including lithium salts on the amounts of cis and trans olefins produced in the Wittig reaction with aldehydes. However, this publication does not mention a combination of a high chemical yield with a favorable Z / E isomer ratio anywhere.
In de verbindingen met formule 1 staat R voor waterstof of een conventionele carboxyl-beschermende 45 groep. De laatste uitdrukking duidt op beschermende groepen van het type dat conventioneel wordt gebruikt voor amino- of carboxylgroepen in de synthese van cefalosporineverbindingen. Geschikte carboxyl-beschermende groepen omvatten aralkylgroepen zoals benzyl, p-methoxybenzyl, o-nitrobenzyl, p-nitrobenzyl, en difenylmethyl (benzhydryl), alkyigroepen zoals t-butyl; halogeenalkylgroepen zoals 2,2,2-trichloorethyl, alkenylgroepen zoals allyl, 2-chloorallyl, alkoxymethylgroepen zoals methoxymethyl, 50 2-(trimethylsilyl)ethyl, trimethylsilyl, tert-butyldimethyl-silyl, tert-butyldifenylsilyl, en andere carboxyl- beschermende groepen die in de literatuur zijn beschreven, zoals bijvoorbeeld in het Britse octrooischrift 1.399.086. Bij voorkeur worden carboxyl-beschermende groepen gebruikt die gemakkelijk kunnen worden verwijderd door behandeling met zuur, in het bijzonder benzhydryl of t-butyl. De bereiding van de zuuradditiezouten en de metaalzouten van de genoemde stof waarin R waterstof voorstelt, maken ook deel uit 55 van de onderhavige uitvinding.In the compounds of formula 1, R represents hydrogen or a conventional carboxyl protecting 45 group. The latter expression refers to protecting groups of the type conventionally used for amino or carboxyl groups in the synthesis of cephalosporin compounds. Suitable carboxyl protecting groups include aralkyl groups such as benzyl, p-methoxybenzyl, o-nitrobenzyl, p-nitrobenzyl, and diphenylmethyl (benzhydryl), alkyl groups such as t-butyl; haloalkyl groups such as 2,2,2-trichloroethyl, alkenyl groups such as allyl, 2-chloroallyl, alkoxymethyl groups such as methoxymethyl, 50 2- (trimethylsilyl) ethyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, and other carboxyl protecting groups which the literature has been described, such as, for example, in British Pat. No. 1,399,086. Preferably, carboxyl protecting groups are used which can be easily removed by treatment with acid, in particular benzhydryl or t-butyl. The preparation of the acid addition salts and the metal salts of said substance wherein R represents hydrogen are also part of 55 of the present invention.
De synthetisch bruikbare zuuradditiezouten omvatten de zouten van formule 1 met minerale zuren zoals waterstofchloride, zwavelzuur en fosforzuur, met organische sulfonzuren, zoals p-tolueensulfonzuur en 192205 2 andere zuren die op het gebied van cefalosporinen bekend en toegepast zijn.The synthetically useful acid addition salts include the salts of formula 1 with mineral acids such as hydrogen chloride, sulfuric acid and phosphoric acid, with organic sulfonic acids such as p-toluenesulfonic acid and 192205 other acids known and used in the field of cephalosporins.
De stoffen met formule 1 waarin R waterstof voorstelt, vormen ook metaalzouten. Synthetisch geschikte metaalzouten omvatten natrium-, kalium-, calcium-, magnesium-, aluminium- en zinkzouten.The substances of formula 1 in which R represents hydrogen also form metal salts. Synthetically suitable metal salts include sodium, potassium, calcium, magnesium, aluminum and zinc salts.
De verbindingen welke bij voorkeur volgens de uitvinding bereid worden, zijn: 5 1. Difenylmethyl-7p-amino-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carboxylaat, 2. Difenylmethyl-7p-amino-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carboxylaathydrochloride, 3. Difenylmethyl^-amino-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carboxylaatsulfaat, 4. Natrium-73-amino-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carboxylaat, 5. Kalium-7p-amino-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carboxylaat, en 10 6. 7p-Amino-3-[(Z)-1-propen-1-yl]-3-cefem-4-carbonzuur.The compounds which are preferably prepared according to the invention are: 1. Diphenylmethyl-7p-amino-3 - [(Z) -1-propen-1-yl] -3-cephem-4-carboxylate, 2. Diphenylmethyl- 7p-amino-3 - [(Z) -1-propen-1-yl] -3-cephem-4-carboxylate hydrochloride, 3. Diphenylmethyl ^ -amino-3 - [(Z) -1-propen-1-yl] -3-cefem-4-carboxylate sulfate, 4. Sodium-73-amino-3 - [(Z) -1-propen-1-yl] -3-cefem-4-carboxylate, 5. Potassium-7β-amino-3 - [(Z) -1-propen-1-yl] -3-cephem-4-carboxylate, and 10 6,7p-Amino-3 - [(Z) -1-propen-1-yl] -3-cefem -4-carboxylic acid.
Geprefereerde procedures worden in de reactieschema’s A en B getoond.Preferred procedures are shown in reaction schemes A and B.
In reactieschema A is de difenylmethylgroep aangegeven als de geprefereerde carboxyl-beschermende groep. De deskundigen zullen echter begrijpen dat andere carboxyl-beschermende groepen op zichzelf 15 algemeen bekend zijn, gebruikt kunnen worden.In reaction scheme A, the diphenylmethyl group is indicated as the preferred carboxyl protecting group. However, those skilled in the art will appreciate that other carboxyl protecting groups well known per se can be used.
in de Wittig-reactie van de verbinding met formule 5 met aceetaldehyde, is gevonden dat toevoeging van lithiumbromide de opbrengst en de verhouding van Z/E-isomeer van het reactieproduct met formule 4a verbetert. De reactie wordt bij voorkeur uitgevoerd met 5-15 chemische equivalenten, bij voorkeur 10 equivalenten lithiumbromide.in the Wittig reaction of the compound of formula 5 with acetaldehyde, it has been found that addition of lithium bromide improves the yield and ratio of Z / E isomer of the reaction product of formula 4a. The reaction is preferably carried out with 5-15 chemical equivalents, preferably 10 equivalents of lithium bromide.
20 Methyleenchloride is het geprefereerde reactiemedium, dat bij voorkeur een cosolvent bevat zoals dimethylformamide of isopropylalcohol in ondergeschikte hoeveelheden van 1/10 tot 1/3 volumedeel per deel methyleenchloride. Reactietemperaturen in het bereik van -10°C tot +25°C zijn geschikt waarbij temperaturen van 0 tot 25°C de voorkeur hebben. Het Wittig-product met formule 4a wordt in een geschikt organisch oplosmiddel zoals ethylacetaat geëxtraheerd en het extract wordt behandeld met Girard’s reagent 25 T waarbij de 7-aminocef-3-em-verbinding met formule 1a wordt verkregen. Zie procedure 3.Methylene chloride is the preferred reaction medium, which preferably contains a cosolvent such as dimethylformamide or isopropyl alcohol in minor amounts of 1/10 to 1/3 part by volume per part methylene chloride. Reaction temperatures in the range of from -10 ° C to + 25 ° C are suitable, with temperatures from 0 to 25 ° C being preferred. The Wittig product of formula 4a is extracted in a suitable organic solvent such as ethyl acetate and the extract is treated with Girard's reagent 25T to yield the 7-aminocef-3-em compound of formula 1a. See procedure 3.
In de experimentele procedures worden een aantal afkortingen gebruikt, welke de volgende betekenissen hebben:In the experimental procedures, a number of abbreviations are used, which have the following meanings:
Ph = fenylPh = phenyl
EtOAc = ethylacetaat 30 DMF = dimethylformamideEtOAc = ethyl acetate, DMF = dimethylformamide
Procedure 1Procedure 1
Difenylmethyl-7-benzylideenamino-3-trifenylfosfoniomethyl-3-oefem-4-carboxylaatchloride.Diphenylmethyl-7-benzylideneamino-3-triphenylphosphoniomethyl-3-moiety-4-carboxylate chloride.
Aan een suspensie van difenylmethyl-7-amino-3-chloormethyl-3-cefem-4-carboxylaathydrochloride (200 g, 35 0,44 mol) in CH2CI2 (940 ml) werd 1N NaOH (440 ml) toegevoegd bij kamertemperatuur. Het mengsel werd gedurende 10 minuten geschud en de organische laag werd afgescheiden. Aan deze organische laag werd MgS04 (75 g) en benzaldehyde (51 g, 0,48 mol) toegevoegd en men liet het mengsel gedurende 3 uur bij kamertemperatuur staan. Het reactiemengsel werd gefiltreerd en de onoplosbare stoffen werden gewassen met 200 ml CH2CI2. Aan het verenigde filtraat en wasvloeistoffen werd 126 g trifenylfosfine (0,48 mol) 40 toegevoegd. Het mengsel werd geconcentreerd onder verminderde druk tot ongeveer 400 ml en men liet het gedurende 4 dagen staan. De verkregen viskeuze olie werd verdund met 1 liter ethylacetaat en fijngewreven waarbij de titelverbinding zich afscheidde in de vorm van een lichtgeel kristallijn poeder dat door filtratie werd verzameld en onder verminderde druk werd gedroogd. Opbrengst 322 g (96%). Smeltpunt 185 a 190°C (ontleding).To a suspension of diphenylmethyl-7-amino-3-chloromethyl-3-cephem-4-carboxylate hydrochloride (200 g, 0.44 mol) in CH 2 Cl 2 (940 ml) was added 1N NaOH (440 ml) at room temperature. The mixture was shaken for 10 minutes and the organic layer separated. To this organic layer, MgSO 4 (75 g) and benzaldehyde (51 g, 0.48 mol) were added and the mixture was allowed to stand at room temperature for 3 hours. The reaction mixture was filtered and the insolubles were washed with 200 ml CH 2 Cl 2. 126 g of triphenylphosphine (0.48 mol) 40 was added to the combined filtrate and washings. The mixture was concentrated under reduced pressure to about 400 ml and left to stand for 4 days. The viscous oil obtained was diluted with 1 liter of ethyl acetate and triturated to yield the title compound as a pale yellow crystalline powder which was collected by filtration and dried under reduced pressure. Yield 322 g (96%). Melting point 185 to 190 ° C (decomposition).
45 IR: uijSc cm"1 1780, 1720,1630.45 IR: uijSc cm "1 1780, 1720,1630.
UV: λ£&α* nm (e) 260 (24100).UV: λ £ & α * nm (e) 260 (24100).
Procedure 2Procedure 2
Difenylmethyl-7-benzylideenamino-3-[(trifenylfosforanylideen)-methyl]-3-cefem-4-carboxylaat (formule 5).Diphenylmethyl-7-benzylideneamino-3 - [(triphenylphosphoranylidene) -methyl] -3-cephem-4-carboxylate (Formula 5).
50 Een mengsel van difenylmethyl-7-benzylideenamino-3-trifenyl-fosfoniomethyl-3-c efem-4- carboxylaatchloride (322 g, 0,42 mol) en 5N Na2C03 (252 ml) in CH2CI2 (1,6 liter) werd gedurende 15 minuten bij kamertemperatuur heftig geroerd. De organische laag werd afgescheiden, gedroogd boven MgS04 en geconcentreerd tot een volume van ongeveer 500 ml. Het concentraat werd met 1 liter aceton verdund, waarbij geroerd werd, onder vorming van een lichtgeel kristallijn poeder dat door filtratie werd 55 verzameld. De opbrengst van het titelproduct bedroeg 237 (78%) met een smeltpunt bij 195 è 198°C (ontleding).50 A mixture of diphenylmethyl-7-benzylideneamino-3-triphenylphosphoniomethyl-3-cephem-4-carboxylate chloride (322 g, 0.42 mol) and 5N Na 2 CO 3 (252 ml) in CH 2 Cl 2 (1.6 liter) was left for Stirred vigorously for 15 minutes at room temperature. The organic layer was separated, dried over MgSO 4 and concentrated to a volume of about 500 ml. The concentrate was diluted with 1 liter of acetone, with stirring, to form a pale yellow crystalline powder which was collected by filtration. The yield of the title product was 237 (78%) with a melting point at 195-198 ° C (decomposition).
3 192205 IR: Umax cm-1 1770, 1620.3 192205 IR: Umax cm -1 1770, 1620.
UV: λ™ nrn (e) 254 (23000), 389 (22000).UV: λ ™ nrn (e) 254 (23000), 389 (22000).
NMR: SCDC'3 ppm 2,56 & 3,16 (2H, ABq), 5,00 (1H, d, J = 4 Hz), 5,23 (1H, d, J = 4 Hz), 5,47 (1H, d, J = 22 Hz), 6,95 (1H, s), 7,2 è 7,8 (30H, m), 8,55 (1H, s).NMR: SCDC'3 ppm 2.56 & 3.16 (2H, ABq), 5.00 (1H, d, J = 4 Hz), 5.23 (1H, d, J = 4 Hz), 5.47 (1H, d, J = 22Hz), 6.95 (1H, s), 7.2? 7.8 (30H, m), 8.55 (1H, s).
55
Procedure 3Procedure 3
Difenylmethyl-7-amino-3-[(Z)-1-propen-1-yl]-3-cefem-4-carboxylaat-hydrochloride (1a hydrochloride).Diphenylmethyl-7-amino-3 - [(Z) -1-propen-1-yl] -3-cephem-4-carboxylate hydrochloride (1a hydrochloride).
Aan een koude oplossing van LiBr (19 g, 216 mmoi) in een gemengd oplosmiddel van droog dimethylfor-mamide (100 ml) en CH2CI2 (300 ml) werden bij -5°C aceetaldehyde (20 ml, 360 mmol) en difenylmethyl-7-10 benzylideen-amino-3-(trifenylfosforanylideen)methyl -3-cefem-4-carboxylaat (met formule 5) (15 g, 20 mmol) toegevoegd. Men liet het mengsel gedurende 20 uur bij -5°C è -10°C en daama 5 uur bij kamertemperatuur staan. De verkregen lichtbruine oplossing werd geconcentreerd tot een volume van ongeveer 100 ml onder verminderde druk, en werd toegevoegd aan een uit twee lagen bestaand oplosmiddel van ethyl-acetaat (400 ml) en water (400 ml). De bovenste laag werd afgescheiden en verdund met 400 ml isopropy-15 lether. Silicagel (Wako-gel C-100, 40 g) werd aan het mengsel toegevoegd. Het mengsel werd gedurende 5 minuten geschud en gefiltreerd door een kussen van diatomeeënfilterhulpmiddel. Onoplosbare stoffen werden met een gemengd oplosmiddel van ethyiacetaat-isopropylether (1/1, 200 ml) gewassen. De gecombineerde filtraat- en wasvloeistoffen werden geconcentreerd tot een volume van ongeveer 400 ml.Acetaldehyde (20 ml, 360 mmol) and diphenylmethyl-7 were added to a cold solution of LiBr (19 g, 216 mmoi) in a mixed solvent of dry dimethylformamide (100 ml) and CH2Cl2 (300 ml) at -5 ° C. -10 benzylidene-amino-3- (triphenylphosphoranylidene) methyl -3-cephem-4-carboxylate (of formula 5) (15 g, 20 mmol). The mixture was allowed to stand at -5 ° C to -10 ° C for 20 hours and then at room temperature for 5 hours. The resulting light brown solution was concentrated to a volume of about 100 ml under reduced pressure, and was added to a two-layer solvent of ethyl acetate (400 ml) and water (400 ml). The top layer was separated and diluted with 400 ml of isopropyl ether. Silica gel (Wako gel C-100, 40 g) was added to the mixture. The mixture was shaken for 5 minutes and filtered through a pad of diatomaceous filter aid. Insolubles were washed with a mixed solvent of ethyl acetate-isopropyl ether (1/1, 200 ml). The combined filtrate and washings were concentrated to a volume of about 400 ml.
Een 0,5 M Girard-reagens T-oplossing in 60 ml methanol en 6 ml azijnzuur werd aan het bovenstaand 20 vermelde concentraat toegevoegd en het mengsel werd gedurende 15 minuten bij kamertemperatuur geroerd. Het mengsel werd verdampt tot een volume van ongeveer 200 ml, gewassen met 200 ml water, 3 x 20 ml verzadigde waterige NaHC03-oplossing en 20 ml zoutoplossing, in deze volgorde, en gedroogd boven MgS04, behandeld met houtskool en geconcentreerd tot ongeveer 50 ml. Aan het concentraat werd bij kamertemperatuur N HCI in 40 ml methanol toegevoegd en men liet het verkregen mengsel gedurende 25 15 minuten staan. Het mengsel werd verdampt tot ongeveer 30 ml en verdund door toevoeging van 300 ml ether. Het neerslag werd door filtratie verzameld en gedroogd boven Pa05, waarbij 7,9 g van een lichtgeel poeder werd verkregen. Een oplossing van het poeder (7,3 g) in een gemengd oplosmiddel van 80 ml methanol en 80 ml ethylacetaat werd behandeld met houtskool, geconcentreerd tot ongeveer 100 ml, geënt met kristallijn hydrochloride van de titelverbinding, langzaam verdund tot 80 ml ether en gedurende 1 uur 30 geroerd. De afgescheiden kleurloze kristallen werden door filtratie verzameld en onder verminderde druk boven P2Os gedroogd waarbij 6,3 g (71%) van de titelverbinding werd verkregen. Dit product is een mengsel van de isomeren Z en E voor wat betreft de propenylgroep op de 3-plaats (Z/E=9/1 volgens HPLC) (Lichrosorb RP-18, 80% methanol - pH 7,2 fosfaatbuffer, 254 nm, 1 ml/min).A 0.5 M Girard reagent T solution in 60 ml of methanol and 6 ml of acetic acid was added to the above concentrate and the mixture was stirred at room temperature for 15 minutes. The mixture was evaporated to a volume of about 200 ml, washed with 200 ml of water, 3 x 20 ml of saturated aqueous NaHCO 3 solution and 20 ml of brine, in this order, and dried over MgSO 4, treated with charcoal and concentrated to about 50 ml . N HCl in 40 ml of methanol was added to the concentrate at room temperature and the resulting mixture was allowed to stand for 25 minutes. The mixture was evaporated to about 30 ml and diluted by adding 300 ml of ether. The precipitate was collected by filtration and dried over Pa05 to obtain 7.9 g of a pale yellow powder. A solution of the powder (7.3 g) in a mixed solvent of 80 ml of methanol and 80 ml of ethyl acetate was treated with charcoal, concentrated to about 100 ml, inoculated with crystalline hydrochloride of the title compound, diluted slowly to 80 ml of ether and Stirred for 1 hour. The separated colorless crystals were collected by filtration and dried over P2Os under reduced pressure to yield 6.3 g (71%) of the title compound. This product is a mixture of the isomers Z and E for the propenyl group in the 3-position (Z / E = 9/1 by HPLC) (Lichrosorb RP-18, 80% methanol - pH 7.2 phosphate buffer, 254 nm , 1 ml / min).
IR: cm-1 2850,1785,1725.IR: cm-1 2850.1785.1725.
35 UV: nm (E}*,) 287 (173).UV: nm (E} *,) 287 (173).
NMR: 8DMS°-d‘ ppm 1,47 (27/1 OH, d-d, J=7,2 Hz, =CHCH3, cis), 1,74 (3/1 OH, d, J=7 Hz, =CHCH3, trans), 3,47 & 3,8 (elk 1H, d, J=16 Hz), 5,13 (1H, d, J=4,5 Hz, 6-H), 5,23 (1H, d, J=4,5 Hz, 7-H), 5,62 (1H, d-q, J=10 & 7 Hz, 3-CH=CH), 6,24 (1H, d -d J=10 & 2 Hz, 3 -CH), 40 6,81 (1H, s, CHPH2), 7,35 (10H, m, Ph-H).NMR: 8DMS ° -d 'ppm 1.47 (27/1 OH, dd, J = 7.2 Hz, = CHCH3, cis), 1.74 (3/1 OH, d, J = 7 Hz, = CHCH3 , trans), 3.47 & 3.8 (1H, d, J = 16 Hz each), 5.13 (1H, d, J = 4.5 Hz, 6-H), 5.23 (1H, d , J = 4.5 Hz, 7-H), 5.62 (1H, dq, J = 10 & 7 Hz, 3-CH = CH), 6.24 (1H, d -d J = 10 & 2 Hz .3 -CH), 6.81 (1H, s, CHPH2), 7.35 (10H, m, Ph-H).
Procedure 4Procedure 4
Difenylmethyl-7-amino-3-[(Z)-1 -propen-1 -yl]-3-cefem-4-carboxylaat (1a).Diphenylmethyl-7-amino-3 - [(Z) -1-propen-1-yl] -3-cephem-4-carboxylate (1a).
Aan een geroerde suspensie van het hydrochloride van difenylmethyl-7-amino-3-[(Z)-1-propen-1-yl]-3-45 cefem-4-carboxylaat (5 g, 11,3 mmol) in HzO (20 ml) en ethylacetaat (40 ml) werd NaHC03 toegevoegd totdat de pH van het mengsel 8 werd. De organische laag werd gewassen met 5 ml verzadigde waterige NaCI-oplossing, gedroogd boven MgS04 en geconcentreerd tot een volume van ongeveer 20 ml. De verkregen oplossing werd met 10 ml isopropylether verdund en geënt met kristallijne verbinding met formule 1a. Een verdere hoeveelheid isopropylether van 30 ml werd langzaam aan het mengsel toegevoegd terwijl 50 daarbij geroerd werd. Na 15 minuten werden de afgescheiden kleurloze kristallen verzameld door filtratie, gewassen met 10 ml isopropylether en onder verminderde druk boven P205 gedroogd. Men verkreeg 4,3 g (94%) van de titelverbinding (Z/E=9/1 volgens HPLC) (Lichrosorb RP-18 80% methanol - pH 7,2 fosfaatbuffer, 254 nm, 1 ml/min).To a stirred suspension of the hydrochloride of diphenylmethyl-7-amino-3 - [(Z) -1-propen-1-yl] -3-45 cephem-4-carboxylate (5 g, 11.3 mmol) in H 2 O ( 20 ml) and ethyl acetate (40 ml) NaHCO 3 was added until the pH of the mixture became 8. The organic layer was washed with 5 ml of saturated aqueous NaCl solution, dried over MgSO 4 and concentrated to a volume of about 20 ml. The resulting solution was diluted with 10 ml of isopropyl ether and seeded with crystalline compound of formula 1a. A further 30 ml isopropyl ether was slowly added to the mixture while 50 was stirred therein. After 15 minutes, the separated colorless crystals were collected by filtration, washed with 10 ml of isopropyl ether and dried over P2 O5 under reduced pressure. 4.3 g (94%) of the title compound (Z / E = 9/1 by HPLC) were obtained (Lichrosorb RP-18 80% methanol - pH 7.2 phosphate buffer, 254 nm, 1 ml / min).
IR:v^cm“1 3450,1765,1730.IR: v cm 1, 3450,1765,1730.
55 UV: X^H nm (Ej°'°m) 289 (185).55 UV: XHm nm (E1 ° °m) 289 (185).
NMR: 8C0C,3 ppm 1,43 (3H, d-d, J=2 & 7 Hz, CH=CHCH3), 1,66 (2H, br, s, verdween door DaO,NMR: 8C0C, 3 ppm 1.43 (3H, d-d, J = 2 & 7 Hz, CH = CHCH3), 1.66 (2H, br, s, disappeared by DaO,
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72587185A | 1985-04-22 | 1985-04-22 | |
US72587185 | 1985-04-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL8601011A NL8601011A (en) | 1986-11-17 |
NL192205B NL192205B (en) | 1996-11-01 |
NL192205C true NL192205C (en) | 1997-03-04 |
Family
ID=24916301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8601011A NL192205C (en) | 1985-04-22 | 1986-04-21 | Process for preparing 7-amino-3- (Z-1-propenyl) -3-cephem-4-carboxylic acid and esters thereof. |
Country Status (38)
Country | Link |
---|---|
JP (1) | JPS61249989A (en) |
KR (1) | KR860008189A (en) |
CN (1) | CN1015714B (en) |
AR (1) | AR242581A1 (en) |
AT (1) | AT392072B (en) |
AU (1) | AU589170B2 (en) |
BE (1) | BE904646A (en) |
CA (1) | CA1273629A (en) |
CH (1) | CH671399A5 (en) |
CS (1) | CS270435B2 (en) |
CY (1) | CY1571A (en) |
DD (1) | DD244557A5 (en) |
DE (1) | DE3613365A1 (en) |
DK (1) | DK163584C (en) |
EG (1) | EG18001A (en) |
ES (1) | ES8800236A1 (en) |
FI (1) | FI84268C (en) |
FR (1) | FR2580652B1 (en) |
GB (1) | GB2173798B (en) |
GR (1) | GR861065B (en) |
HK (1) | HK106290A (en) |
HU (1) | HU195223B (en) |
IE (1) | IE59014B1 (en) |
IT (1) | IT1228241B (en) |
LU (1) | LU86402A1 (en) |
MY (1) | MY100694A (en) |
NL (1) | NL192205C (en) |
NO (1) | NO164659C (en) |
NZ (1) | NZ215717A (en) |
OA (1) | OA08245A (en) |
PT (1) | PT82436B (en) |
SE (1) | SE500217C2 (en) |
SG (1) | SG90890G (en) |
SU (1) | SU1435155A3 (en) |
YU (1) | YU43697B (en) |
ZA (1) | ZA862985B (en) |
ZM (1) | ZM4286A1 (en) |
ZW (1) | ZW9086A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4708955A (en) * | 1985-06-24 | 1987-11-24 | Bristol-Myers Company | 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof |
US4870168A (en) * | 1987-02-26 | 1989-09-26 | Bristol-Myers Company | 3-Unsaturated alkyl cephems from 3-triflyl cephems |
DE3933934A1 (en) * | 1989-10-03 | 1991-04-11 | Bayer Ag | METHOD FOR PRODUCING 7-AMINO-3 - ((Z) -1-PROPEN-1-YL) -3-CEPHEM-4-CARBONIC ACID |
DK0503453T3 (en) * | 1991-03-08 | 2001-07-16 | Biochemie Gmbh | Process for preparing cephalosporins and intermediates in this process |
SG48415A1 (en) * | 1992-02-05 | 1998-04-17 | Biochemie Gmbh | Process for the purification of a 3-cephem-4-carboxylic acid derivative |
AT399876B (en) * | 1992-02-05 | 1995-08-25 | Biochemie Gmbh | Purificn. of 7-amino-3-((z)-1-propen-1-yl)-3 -cephem-4-carboxylic acid - useful in prodn. of broadband antibiotics |
JPH07173168A (en) * | 1993-07-14 | 1995-07-11 | Sumitomo Chem Co Ltd | Cephem compound, its manufacturing method, and use thereof for the production of cephem antibiotics |
US20060173176A1 (en) * | 2002-10-08 | 2006-08-03 | Yatendra Kumar | Process for the preparation of (z)-isomer enriched 7-amino-3-propen-1-yl-3-cephem-4-carboxylic acid |
WO2005042543A1 (en) | 2003-10-30 | 2005-05-12 | Cj Corporation | Processes for the preparation of cephem derivatives |
JP4046708B2 (en) * | 2004-06-04 | 2008-02-13 | 明治製菓株式会社 | Method for producing 3-alkenylcephem compound |
US20080281093A1 (en) | 2004-11-01 | 2008-11-13 | Bandi Parthasaradhi Reddy | Novel Process For Preparation of Cefprozil Intermediate |
CN103183686B (en) * | 2011-12-30 | 2016-06-29 | 浙江新和成股份有限公司 | The preparation method of 7 beta-amino-7 α-methoxyl group-3-cephem compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769277A (en) * | 1970-01-23 | 1973-10-30 | Glaxo Lab Ltd | Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group |
GB1342241A (en) * | 1970-01-23 | 1974-01-03 | Glaxo Lab Ltd | Cephalosporin compounds |
US4110534A (en) * | 1970-01-23 | 1978-08-29 | Glaxo Laboratories Limited | Process for the preparation of 3-vinyl and substituted vinyl cephalosporins |
US4065620A (en) * | 1971-06-14 | 1977-12-27 | Eli Lilly And Company | 3-(Substituted) vinyl cephalosporins |
US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
US4520022A (en) * | 1983-01-28 | 1985-05-28 | Bristol-Myers Company | Substituted vinyl cephalosporins |
AU566944B2 (en) * | 1983-10-07 | 1987-11-05 | Gist-Brocades N.V. | Preparation of 3-cephem derivatives |
-
1986
- 1986-03-21 FR FR8604051A patent/FR2580652B1/en not_active Expired
- 1986-04-07 NZ NZ215717A patent/NZ215717A/en unknown
- 1986-04-11 NO NO861430A patent/NO164659C/en unknown
- 1986-04-16 SU SU864027263A patent/SU1435155A3/en active
- 1986-04-16 AU AU56168/86A patent/AU589170B2/en not_active Expired
- 1986-04-17 EG EG219/86A patent/EG18001A/en active
- 1986-04-17 FI FI861634A patent/FI84268C/en not_active IP Right Cessation
- 1986-04-18 AR AR86303699A patent/AR242581A1/en active
- 1986-04-18 CA CA000507037A patent/CA1273629A/en not_active Expired - Lifetime
- 1986-04-21 CN CN86102630A patent/CN1015714B/en not_active Expired
- 1986-04-21 ZW ZW90/86A patent/ZW9086A1/en unknown
- 1986-04-21 CH CH1601/86A patent/CH671399A5/de not_active IP Right Cessation
- 1986-04-21 BE BE0/216572A patent/BE904646A/en not_active IP Right Cessation
- 1986-04-21 HU HU861664A patent/HU195223B/en unknown
- 1986-04-21 CS CS862872A patent/CS270435B2/en not_active IP Right Cessation
- 1986-04-21 IE IE104886A patent/IE59014B1/en not_active IP Right Cessation
- 1986-04-21 DE DE19863613365 patent/DE3613365A1/en active Granted
- 1986-04-21 DK DK182486A patent/DK163584C/en not_active IP Right Cessation
- 1986-04-21 IT IT8620162A patent/IT1228241B/en active
- 1986-04-21 ZA ZA862985A patent/ZA862985B/en unknown
- 1986-04-21 OA OA58840D patent/OA08245A/en unknown
- 1986-04-21 LU LU86402A patent/LU86402A1/en unknown
- 1986-04-21 ZM ZM42/86A patent/ZM4286A1/en unknown
- 1986-04-21 SE SE8601825A patent/SE500217C2/en not_active IP Right Cessation
- 1986-04-21 DD DD86289446A patent/DD244557A5/en unknown
- 1986-04-21 GB GB08609661A patent/GB2173798B/en not_active Expired
- 1986-04-21 ES ES554215A patent/ES8800236A1/en not_active Expired
- 1986-04-21 PT PT82436A patent/PT82436B/en unknown
- 1986-04-21 NL NL8601011A patent/NL192205C/en not_active IP Right Cessation
- 1986-04-22 JP JP61091419A patent/JPS61249989A/en active Granted
- 1986-04-22 YU YU659/86A patent/YU43697B/en unknown
- 1986-04-22 KR KR1019860003085A patent/KR860008189A/en not_active Application Discontinuation
- 1986-04-22 AT AT0106786A patent/AT392072B/en not_active IP Right Cessation
- 1986-04-22 GR GR861065A patent/GR861065B/en unknown
-
1987
- 1987-09-29 MY MYPI87002270A patent/MY100694A/en unknown
-
1990
- 1990-11-09 SG SG908/90A patent/SG90890G/en unknown
- 1990-12-18 HK HK1062/90A patent/HK106290A/en not_active IP Right Cessation
-
1991
- 1991-12-20 CY CY1571A patent/CY1571A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL192205C (en) | Process for preparing 7-amino-3- (Z-1-propenyl) -3-cephem-4-carboxylic acid and esters thereof. | |
CA1110231A (en) | 7.beta.-AMINO-CEPHAM-3-ONE-4-CARBOXYLIC ACIDS | |
US4296236A (en) | 7-(or 6-) Substituted-7-(or 6-)acylimino cephalosporin (or penicillin) compounds | |
IE43845B1 (en) | 4-thia-1-azabicyclo/4.2.0/oct-2-ene derivatives | |
US4122086A (en) | Isopenicillins | |
US4699979A (en) | 7-amino-3-propenylcephalosporanic acid and esters thereof | |
US4139618A (en) | Cephalosporin type antibacterials | |
US4888429A (en) | Process for producing allyl aminothiazole acetate intermediates | |
US5925632A (en) | Derivatives of 3-pyrrolidylidene-2-one-cephalsporines | |
FI75165B (en) | FOERBAETTRAT FOERFARANDE FOER FRAMSTAELLNING AV PENICILLANSYRAKLORMETYLESTRAR. | |
US4145540A (en) | 7β-Phosphoramido-7α-methoxycephalosporanic acid derivatives | |
US4564676A (en) | Process for preparing cephalosporin derivatives | |
AU619201B2 (en) | Process for the preparation of 3-exomethylene cepham derivatives | |
US4051129A (en) | Process for preparing 7-methoxycephalosporin compounds | |
US4048155A (en) | Process for preparing 7 α-alkoxycephalosporin derivatives | |
US4959495A (en) | Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins | |
US4334063A (en) | Cephalosporin vinyl halides | |
US4079179A (en) | 6-Loweralkoxy or loweralkylthio-3-cephem-4-carboxylic acids | |
CA1052373A (en) | Cephalosporin and penicillin derivatives | |
DE2455358A1 (en) | CEPHALOSPORINE SULFOXIDE THIO-SUBSTITUTED IN 2-POSITION | |
US4558124A (en) | Preparation of cephalosporin intermediate compounds | |
US4560750A (en) | Cephem compounds and process for preparing the same | |
US4166904A (en) | ⊕-lactam containing compounds | |
US3993758A (en) | Cephalosporin compounds | |
US4299954A (en) | Cephalosporin vinyl halides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: BRISTOL-MYERS SQUIBB COMPANY |
|
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Effective date: 20060421 |